Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...
GlobalData on MSN12d
ViiV Healthcare to increase annual supply of long-acting HIV PrEPThe announcement marks another important milestone in our efforts to accelerate access to the only long-acting PrEP available ...
ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...
ViiV Healthcare sponsored events to address the climbing rates of HIV infections on HBCU campuses and the surrounding Black ...
Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...
The survey also found that flexible and virtual appointments, as well as transportation support, were helpful while on ...
The Indian Patent Office has rejected Viiv Healthcare's patent application for the HIV drug, dolutegravir, after nearly a ...
At Alabama State University's homecoming, ViiV Healthcare partnered with the campus to raise awareness about HIV prevention, ...
ViiV Healthcare’s latest HIV prevention campaign coincided with one of the biggest weekends of the year at Alabama State ...
13d
ViiV’s strategy for CAB LA for PrEP in L&MICs is to maximise rapid access and uptake for populations with highest unmet needs ...
London, [16 OCTOBER 2024] – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of new real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback